Qvt Financial LP Xencor Inc Transaction History

Qvt Financial LP

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2017 Feb 14, 2018	SELL	$19.29 - $24.83 $3.79 Million - $4.88 Million	-196,537 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$19.61 - $23.35 $3.85 Million - $4.59 Million	196,537	196,537 $4.51 Million

215

71.8M

2.5K

7.9K

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.38B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

Get notified when there are updates to the investment portfolio of Qvt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Qvt Financial LP with notifications on news.